In this interview, News-Medical talks to Dr. Amy Sheng and Dr. Lurong Pan about how AI computing can be used in combination with high throughput production and screening to enhance the development ...

Recombinant antibody technology has helped address many problems associated with hybridoma platforms, opening the door to a new class of biologic drugs.

The market’s value in 2020 was USD 656.64 billion, and with an extremely high CAGR of 21.36% is expected to attain a value of USD 1.378 trillion by 2030 according to Strategic Market Research ...

<i> Technology Networks </i> spoke with Isaku Tanida, Head of Protein and Pathway Technologies, Life Science at Merck to learn about Merck's ZooMAb® recombinant antibodies. These antibodies are ...

Today, Open Monoclonal Technology, Inc. (OMT) and Recombinant Antibody Technology, Ltd (RAT) announced a publication about OmniRat™ in the Journal of ...

Researchers at the USC School of Pharmacy indicate that recombinant DNA technology may allow for oral administration of drugs that previously could only be given by injection.

Key findings from the research conducted by Mr. González determined that it is possible to scale up production of both proenzymes trypsinogen and chymotrypsinogen using recombinant technology ...

Technology Networks spoke with Isaku Tanida, Head of Protein and Pathway Technologies, Life Science at Merck to learn about Merck's ZooMAb® recombinant antibodies. These antibodies are developed from ...